We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA’s Clinical Trial Transparency Initiative Put on Hold — For Now
EMA’s Clinical Trial Transparency Initiative Put on Hold — For Now
The European Medicines Agency has postponed indefinitely a controversial transparency initiative that would make publicly available detailed information from clinical study reports contained in new drug applications.